University of Rochester: Prostatic Neoplasms trials

The registry lists 10 Prostatic Neoplasms studies with University of Rochester as lead sponsor. 4 are open to participants now and 2 have results posted.

Early Phase 1 2Phase 2 3Phase 3 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effect of Text Message Reminders on M-ISI Score After Prostate SurgeryRecruitingNCT07071207Not applicable
• This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.RecruitingNCT05946824Phase 2
• Vitamin D for Prostate Endocrine TherapyRecruitingNCT05838716Phase 3
• A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate CancerRecruitingNCT05530655Early Phase 1
• Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate CancerCompletedNCT04731844Phase 2Results posted
• Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.CompletedNCT02213107Phase 2Results posted
• A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only RecurrenceWithdrawnNCT04645810Not applicable
• Cisplatin in Castration Resistant Prostate CancerCompletedNCT03275857Early Phase 1
• High-dose Vitamin D Supplementation for ADT-induced Side EffectsCompletedNCT02064946Not applicable
• Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate CancerCompletedNCT00003903Not applicable